FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Panel to Discuss Pediatric Brain Tumors

[ Price : $8.95]

Federal Register Notice: FDAs Pediatric Oncology Subcommittee will meet 12/6 to consider endpoints for trials that are studying dr...

Devices Submissions Rose Last Year

[ Price : $8.95]

CDRH says medical device major submissions to FDA last year rose slightly (2%), from 8,536 in 2004 to 8,714 in 2005.

Exelixis Suspends Enrollment in Cancer Drug Trial

[ Price : $8.95]

Exelixis Inc. suspends enrollment in a clinical trial involving its experimental cancer drug XL999 due to concerns about reported ...

Advancis to File Once-daily Amoxicillin NDA

[ Price : $8.95]

Advancis Pharmaceutical Corp. says it will file an NDA next month for its amoxicillin Pulsys once-daily product.

Crawford, Downtrodden FDAers, Compliance are Top Stories

[ Price : $8.95]

Ex-commissioner Crawfords guilty plea dominates reader interest in October, followed by a lawyers view of downtrodden FDA staff an...

How Would You Like to be FDA Commissioner?

[ Price : $8.95]

FDA Webview editor James G. Dickinson answers the question, How would you like to be FDA commissioner? and invites readers to subm...

Boehringer Ingelheim Asks CFC Delay

[ Price : $8.95]

Boehringer Ingelheim asks FDA allow its Combivent to remain on the market until the company develops a CFC-free replacement.

Bed System Guide Published

[ Price : $8.95]

CDRH publishes a guide for modifying bed systems to reduce changes of entrapment.

Workshop on Marketed, Unapproved Drugs

[ Price : $8.95]

Federal Register Notice: FDA plans a public workshop 1/9/07 to guide businesses in seeking approval for marketed unapproved drugs.

Pfizer Says Experimental Cholesterol Drug Raises BP

[ Price : $8.95]

Pfizer says preliminary results of its experimental cholesterol-lowering drug torcetrapib show an unexpected increase in patients ...